Health BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Turning Point Therapeutics, Inc. (Nasdaq – TPTX), UB Bancorp (OTC – UBNC), Sprague Resources LP (NYSE – SRLP), Gesher I Acquisition Corp. (Nasdaq – GIAC) June 6, 2022
Health FDA APPROVES RIABNI(TM) (RITUXIMAB-ARRX), A BIOSIMILAR TO RITUXAN® (RITUXIMAB), FOR ADULTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS June 6, 2022
Health Biogen and Alectos Therapeutics Announce License and Collaboration Agreement for AL01811, a Novel GBA2 Inhibitor for the Potential Treatment of Parkinson’s Disease June 6, 2022
Health Final Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Filed Against AbbVie, Inc. (ABBV) June 5, 2022
Health NEW HEAD-TO-HEAD DATA SHOW VECTIBIX® (PANITUMUMAB) DEMONSTRATED SUPERIOR OVERALL SURVIVAL COMPARED TO BEVACIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN JAPANESE PATIENTS WITH WILD-TYPE RAS COLORECTAL CANCER June 5, 2022
Health Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds AbbVie, Inc. (ABBV) Investors with Substantial Losses to Contact the Firm June 4, 2022
Health Everest Medicines’ Licensing Partner Gilead Sciences Announces Positive Results from Phase 3 TROPiCS-02 Study of Trodelvy® in Heavily Pre-treated HR+/HER2- Metastatic Breast Cancer Patients June 4, 2022
Search
health sector stocks
